Adenosine 5'-monophosphateCAS# 61-19-8 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 61-19-8 | SDF | Download SDF |
| PubChem ID | 6083 | Appearance | Powder |
| Formula | C10H14N5O7P | M.Wt | 347 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 16.67 mg/mL (48.01 mM; Need ultrasonic) H2O : 1.67 mg/mL (4.81 mM; Need ultrasonic) | ||
| Chemical Name | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | ||
| SMILES | C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O | ||
| Standard InChIKey | UDMBCSSLTHHNCD-KQYNXXCUSA-N | ||
| Standard InChI | InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Adenosine 5'-monophosphate Dilution Calculator
Adenosine 5'-monophosphate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8818 mL | 14.4092 mL | 28.8184 mL | 57.6369 mL | 72.0461 mL |
| 5 mM | 0.5764 mL | 2.8818 mL | 5.7637 mL | 11.5274 mL | 14.4092 mL |
| 10 mM | 0.2882 mL | 1.4409 mL | 2.8818 mL | 5.7637 mL | 7.2046 mL |
| 50 mM | 0.0576 mL | 0.2882 mL | 0.5764 mL | 1.1527 mL | 1.4409 mL |
| 100 mM | 0.0288 mL | 0.1441 mL | 0.2882 mL | 0.5764 mL | 0.7205 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Dibucaine (Cinchocaine) HCl
Catalog No.:BCC3760
CAS No.:61-12-1
- 2-Methoxycinnamic acid
Catalog No.:BCN5038
CAS No.:6099-03-2
- Geraniin
Catalog No.:BCN2402
CAS No.:60976-49-0
- Bz-Glu-OH
Catalog No.:BCC2922
CAS No.:6094-36-6
- YZ9
Catalog No.:BCC8001
CAS No.:6093-71-6
- 6-Hydroxycoumarin
Catalog No.:BCC9207
CAS No.:6093-68-1
- H-DL-Pro-OH
Catalog No.:BCC3026
CAS No.:609-36-9
- PIR 3.5
Catalog No.:BCC6128
CAS No.:6088-51-3
- Ligularidine
Catalog No.:BCN2141
CAS No.:60872-63-1
- Crotaverrine
Catalog No.:BCN2142
CAS No.:60827-69-2
- Esculentoside B
Catalog No.:BCN5011
CAS No.:60820-94-2
- Apremilast (CC-10004)
Catalog No.:BCC2273
CAS No.:608141-41-9
- Papaverine Hydrochloride
Catalog No.:BCC8348
CAS No.:61-25-6
- Mefenamic Acid
Catalog No.:BCC4433
CAS No.:61-68-7
- Phenylephrine HCl
Catalog No.:BCC4335
CAS No.:61-76-7
- 4-Aminohippuric Acid
Catalog No.:BCC4753
CAS No.:61-78-9
- Zoxazolamine
Catalog No.:BCC4751
CAS No.:61-80-3
- H-Leu-OH
Catalog No.:BCC2968
CAS No.:61-90-5
- Tenuazonic acid
Catalog No.:BCN1859
CAS No.:610-88-8
- Isoacetovanillone
Catalog No.:BCN7166
CAS No.:6100-74-9
- Succinylcholine Chloride Dihydrate
Catalog No.:BCC4564
CAS No.:6101-15-1
- Ferulamide
Catalog No.:BCN4129
CAS No.:61012-31-5
- c-JUN peptide
Catalog No.:BCC8085
CAS No.:610273-01-3
- Teicoplanin
Catalog No.:BCC4731
CAS No.:61036-62-2
Linseed oil can decrease liver fat deposition and improve antioxidant ability of juvenile largemouth bass, Micropterus salmoides.[Pubmed:30945042]
Fish Physiol Biochem. 2019 Apr 3. pii: 10.1007/s10695-019-00636-3.
A feeding trial was conducted to evaluate the effect of linseed oil (LO) on growth, plasma biochemistry, hepatic metabolism enzymes, and antioxidant capacity of juvenile largemouth bass, Micropterus salmoides. Four isonitrogenous (crude protein, 45%) and isoenergetic (gross energy, 18 MJ/kg) diets were formulated by replacing 0 (the control), 33.3%, 66.7%, and 100% of fish oil with linseed oil. Each diet was fed to three replicate groups of fish (initial body weight, 22.02 +/- 0.61 g) for 8 weeks. The results indicated that fish fed diet with 100% LO substitution level had lower weight gain (WG), specific growth rate (SGR), and protein efficiency ratio (PER) than the other groups (P < 0.05), while feed conversion ratio (FCR) was higher compared to the other groups (P < 0.05). Feed intake (FI) and hepatosomatic index (HSI) of 66.7% LO substitution level were significantly lower than the control groups (P < 0.05). Glycogen, lipid, and non-esterified fatty acid content in the liver decreased significantly with increasing dietary LO levels (P < 0.05). Moreover, the replacement of fish oil (FO) with LO could significantly reduce the content of triglyceride (TG) and total cholesterol (TC) and the activity of alanine amiotransferase (ALT) in plasma of M. salmoides (P < 0.05). There were significant differences in hepatic metabolism enzymes in fish fed diets with different dietary LO levels. Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR-alpha) activities in liver significantly increased with increasing dietary LO level (P < 0.05). In addition, phosphoenolpyruvate carboxykinase (PEPCK) and fructose-1,6-bisphosphatase (FBPase) activities in the liver significantly increased with decreasing dietary LO level (P < 0.05). Both the lowest superoxide dismutase (SOD) and catalase (CAT) activities in the liver were recorded in the control group (P < 0.05). Moreover, nitric oxide content, glutathione peroxidase (GPx), and inducible nitric oxide synthase (iNOS) activities in the liver significantly increased with increasing dietary LO level, while malondialdehyde (MDA) content significantly reduced. These findings demonstrated that LO can improve liver function and antioxidant ability of M. salmoides. In addition, replacing partial FO with LO cannot affect growth performance, but all substitutions inhibit growth performance of M. salmoides.
